If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

Doctors explain how conditions like psoriasis, type 1 diabetes, and inflammatory bowel disease impact men, plus how these ...

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical ...

The FamilyPso questionnaire revealed caregiver burden among partners and family members of patients with psoriasis, which ...

Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients: Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hr ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% ...

This link between central fat and ... Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Some people can get hives (itchy raised bumps that look red on lighter skin and brown or purple on darker skin) after hot ...

Landmark resolution at the 78th WHA recognizes skin diseases as a global public health priority, urging action worldwide.

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...